Ross Wilson (@RossWilsonLab) header
Ross Wilson (@RossWilsonLab) profile picture

CRISPR whisperer in perpetual training. We're working to enable safe & accessible delivery of genome editing therapeutics. @igisci @UCBerkeley https://xitter.twitterapi.xyz/t.co/89o53zRYUa

Joined December 2019
Photo by Ross Wilson (@RossWilsonLab)Photo by Ross Wilson (@RossWilsonLab)Photo by Ross Wilson (@RossWilsonLab)Photo by Ross Wilson (@RossWilsonLab)Photo by Ross Wilson (@RossWilsonLab)Photo by Ross Wilson (@RossWilsonLab)Photo by Ross Wilson (@RossWilsonLab)Photo by Ross Wilson (@RossWilsonLab)Photo by Ross Wilson (@RossWilsonLab)Photo by Ross Wilson (@RossWilsonLab)
Introducing PERCEPT, a non-viral CRISPR delivery platform for in vivo genome editing! We reversibly attach peptides and polymers to CRISPR enzymes, driving editing in the brain, retina, muscle, or lungs of mice via local delivery. 🧵below, bioRxiv🔗bit.ly/PERCEPTpre
5
46
5
195
13,199
A central finding: the best delivery chemistry (which defines PERCEPT) depended on the tissue. P55 + PEG performed best in lung, while S315 + PEG performed best in muscle. PERCEPT turns protein surface chemistry into a modular toolkit for expanding the reach of genome editing.
1
3
179
Massive credit goes to Chris Baehr @baehr_chris, who led this work, as well as Alzbeta Ressnerova, Min Kang, Sheng Zhao, Beatrice Le, Rania Haddad & Kunica Asija; Niren Murthy, John Flannery, Victor Van Laar, and Russ Lonser... and all our collaborators!
3
187
🧬 Can CRISPR dial down α-synuclein instead of knocking it out? MTI winners Ross Wilson & Hanqin Li aim to halt Lewy bodies with precision base editing - $90 K + full platform support. #CRISPR #Parkinsons #MTIAwards 🔗 Read more at moleculartherapeutics.org/20…
4
2
1
5
396
Ross Wilson retweeted
Inaugural post! (after a long hiatus) Last May I quit my job to build @dittobio with @Mezarque and @emilycpierce ! We turn parasite molecules into drugs for autoimmune disease, and are part of the @ycombinator W26 batch. Thanks for betting on us @agupta
2
6
3
26
3,772
Big news! Our team developed Neuro-PERC, a non-viral CRISPR delivery platform for genome editing of the brain. In our new preprint - bit.ly/NeuroPERC_pre - we report efficient editing in multiple models & species, including field-first results in large animals (pigs) 🧵👇
2
9
1
22
1,843
Together, these findings establish Neuro-PERC as a versatile, scalable, well-tolerated platform… as well as a promising candidate for clinical translation in neurotherapeutics. 🐭🐷🧠🧬✂️
1
213
Huge credit to @BrigetteManohar for leading this collaborative effort based at IGI & @berkeleyMCB, which would have been impossible without major contributions from OSU's @TNeuroSci_Lab @RussellLonser and support from NIH's SCGE consortium @somaticediting
1
1
261